ISRCTN ISRCTN06221064
DOI https://doi.org/10.1186/ISRCTN06221064
Secondary identifying numbers N/A
Submission date
06/09/2008
Registration date
29/09/2008
Last edited
29/09/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Ms Jo Watson
Scientific

98 Bessborough Drive
Toronto
M4G 3J1
Canada

Study information

Study designSingle site randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleThe effect of conservative versus routine intrapartum fluid management in women with epidural analgesia on breastfed newborn weight loss: a randomised controlled trial
Study acronymThe FILL Trial
Study objectivesFor low risk women receiving epidural analgesia in labour, what is the effect of a conservative protocol for fluid management versus usual care on breastfed newborns’ weight loss in the first 48 hours of life?
Ethics approval(s)Ethics approval received from the Research Ethics Board of Sunnybrook Health Sciences Centre on the 21st August 2008 (ref: 237-2008)
Health condition(s) or problem(s) studiedFluid management in labour
InterventionTotal duration of treatment is from the time of admission to the labour unit until the time of delivery. Patients will be randomised to one of the following fluid management techniques:

Usual Intrapartum Fluid Management:
Usual intrapartum fluid management includes the initiation of intravenous therapy prior to epidural analgesia administration or when intravenous drugs need to be administered. Fluid preload for epidural analgesia initiation ranges from 500 cc to 1000 cc of Ringers Lactate and intravenous (IV) fluid is administered throughout labour for non-reassuring foetal heart rate tracings and maternal fever. Hourly infusion volumes vary from 125 to 250 ml per hour or greater. Calculations of fluid balance may not be routinely conducted intrapartum but summarised at the time of transfer of the woman to the postpartum floor. Intrapartum assessments do not routinely include hydration assessments or calculation of intrapartum fluid balance.

Conservative Fluid Management:
A conservative intrapartum fluid management protocol will be administered to the experimental group. This protocol assumes that care is individualised to the labouring woman and will be reflective of the events of her labour. Women will receive an epidural analgesia preload of 250 to 500 ml of Ringers Lactate and the intravenous infusion will continue at the hourly rate of 75 to 100 ml per hour. Hydration assessments and fluid balance calculations will be conducted and recorded every four hours. Reaching critical values for fluid infused greater than 2500 ml will require the nurse to review the fluid management plan with the physician responsible for the woman's care, maternal fever will be treated with acetaminophen. Decisions regarding bolus for abnormal foetal heart rate patterns will at the discretion of the caregivers.
Intervention typeOther
Primary outcome measureBreastfed newborn weight loss in the first 48 hours.
Secondary outcome measuresBreastfeeding exclusivity, measured prior to discharge from the postpartum unit.
Overall study start date15/10/2008
Completion date15/10/2009

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participants200
Key inclusion criteria1. Women in early labour, 19 - 40 years of age
2. Experiencing a labour at no identified risk
3. Anticipating a vaginal birth
4. Planning to breastfeed
5. Requesting an epidural
Key exclusion criteria1. Planning discharge before 48 hours
2. Unable to read and write English
3. Previous breast surgery
4. Expected to deliver in the next 4 - 5 hours
Date of first enrolment15/10/2008
Date of final enrolment15/10/2009

Locations

Countries of recruitment

  • Canada

Study participating centre

98 Bessborough Drive
Toronto
M4G 3J1
Canada

Sponsor information

Sunnybrook Health Sciences Centre (Canada)
Hospital/treatment centre

2075 Bayview Avenue
Toronto
M4N 3M5
Canada

Website http://www.sunnybrook.ca/
ROR logo "ROR" https://ror.org/03wefcv03

Funders

Funder type

Research organisation

Society of Obstetricians and Gynaecologists (Canada) - Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) Fellowship

No information available

Sunnybrook Health Sciences Centre (Canada)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan